Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

408
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
408
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

448
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
448
Autoimmune Disorders01:29

Autoimmune Disorders

1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

818
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
818

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leptin drives osteoarthritis pain through sensory neuron reprogramming independent of cartilage signaling.

bioRxiv : the preprint server for biology·2026
Same author

The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response Criteria.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Gender Equity in Rheumatology Research: Global Analysis of Authors.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

The Painful Truth: The Relationship Between Nonarticular Pain and Patient Global Assessment Before and After Initiating a New Disease-Modifying Antirheumatic Drug for Active Rheumatoid Arthritis.

Arthritis care & research·2026
Same author

Health-Related Behaviors Associated With Knee Pain Increase: A Longitudinal Community-Based Cohort Study That Examines Osteoarthritis.

ACR open rheumatology·2026
Same author

Obesity Subtypes and Longitudinal Trajectories of Function Over Seven Years of Follow-Up: Data From the Multicenter Osteoarthritis Study.

Arthritis care & research·2026

Related Experiment Video

Updated: Jan 9, 2026

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.8K

Osteoarthritis as a systemic disease.

Kelsey H Collins1,2, Ida K Haugen3,4, Tuhina Neogi5

  • 1Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA, USA. kelsey.collins@ucsf.edu.

Nature Reviews. Rheumatology
|December 3, 2025
PubMed
Summary
This summary is machine-generated.

Osteoarthritis (OA) is a systemic disease, not just joint wear-and-tear. Viewing OA holistically offers new therapeutic strategies and insights into chronic diseases.

More Related Videos

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
06:06

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

Published on: July 22, 2021

6.7K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

6.0K

Related Experiment Videos

Last Updated: Jan 9, 2026

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.8K
Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
06:06

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

Published on: July 22, 2021

6.7K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

6.0K

Area of Science:

  • Rheumatology and immunology
  • Systemic disease research
  • Drug development

Background:

  • Osteoarthritis (OA) traditionally viewed as joint wear-and-tear.
  • Limited understanding of OA as a systemic disease.
  • Current OA treatments focus on specific joint tissues, hindering progress.

Purpose of the Study:

  • Shift understanding of OA from localized to systemic disease.
  • Explore novel therapeutic targets beyond joint tissues.
  • Address challenges in translating preclinical OA research to clinical practice.

Main Methods:

  • Review of preclinical and clinical data.
  • Analysis of OA as a whole-body disease.
  • Consideration of systemic factors and inter-organ crosstalk.

Main Results:

  • OA involves dysfunctional cellular metabolism and matrix degradation.
  • Pro-inflammatory innate immunity pathways are activated in OA.
  • Systemic changes contribute to OA development and progression.

Conclusions:

  • Reconceptualizing OA as a systemic disease is crucial.
  • Treating pain separately from structural damage may be viable.
  • Integrating new technologies can advance OA drug development and chronic disease research.